Baxter PE Ratio 2010-2025 | BAX
Current and historical p/e ratio for Baxter (BAX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Baxter PE ratio as of June 10, 2025 is 12.15.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Baxter PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-10 | 31.72 | 0.00 | |
| 2025-03-31 | 34.04 | $-1.10 | 0.00 |
| 2024-12-31 | 28.86 | $-1.28 | 0.00 |
| 2024-09-30 | 37.39 | $0.20 | 186.93 |
| 2024-06-30 | 32.68 | $4.86 | 6.73 |
| 2024-03-31 | 41.40 | $5.20 | 7.96 |
| 2023-12-31 | 37.19 | $5.22 | 7.12 |
| 2023-09-30 | 36.01 | $5.10 | 7.06 |
| 2023-06-30 | 43.17 | $-5.66 | 0.00 |
| 2023-03-31 | 38.16 | $-4.88 | 0.00 |
| 2022-12-31 | 47.62 | $-4.83 | 0.00 |
| 2022-09-30 | 50.06 | $-4.72 | 0.00 |
| 2022-06-30 | 59.40 | $2.00 | 29.70 |
| 2022-03-31 | 71.42 | $2.09 | 34.17 |
| 2021-12-31 | 78.81 | $2.53 | 31.15 |
| 2021-09-30 | 73.57 | $2.39 | 30.78 |
| 2021-06-30 | 73.37 | $2.19 | 33.50 |
| 2021-03-31 | 76.60 | $2.08 | 36.83 |
| 2020-12-31 | 72.65 | $2.14 | 33.95 |
| 2020-09-30 | 72.58 | $1.76 | 41.24 |
| 2020-06-30 | 77.49 | $1.78 | 43.53 |
| 2020-03-31 | 72.87 | $1.96 | 37.18 |
| 2019-12-31 | 74.86 | $1.98 | 37.81 |
| 2019-09-30 | 78.10 | $2.68 | 29.14 |
| 2019-06-30 | 72.94 | $2.97 | 24.56 |
| 2019-03-31 | 72.21 | $2.94 | 24.56 |
| 2018-12-31 | 58.30 | $2.99 | 19.50 |
| 2018-09-30 | 68.10 | $2.21 | 30.81 |
| 2018-06-30 | 65.06 | $1.66 | 39.19 |
| 2018-03-31 | 57.15 | $1.51 | 37.85 |
| 2017-12-31 | 56.67 | $1.29 | 43.93 |
| 2017-09-30 | 54.88 | $1.86 | 29.50 |
| 2017-06-30 | 52.81 | $1.65 | 32.00 |
| 2017-03-31 | 45.11 | $3.36 | 13.43 |
| 2016-12-31 | 38.47 | $8.99 | 4.28 |
| 2016-09-30 | 41.18 | $8.92 | 4.62 |
| 2016-06-30 | 39.01 | $8.68 | 4.49 |
| 2016-03-31 | 35.34 | $7.09 | 4.98 |
| 2015-12-31 | 32.72 | $1.75 | 18.70 |
| 2015-09-30 | 28.09 | $3.12 | 9.00 |
| 2015-06-30 | 32.38 | $3.98 | 8.14 |
| 2015-03-31 | 31.72 | $4.33 | 7.33 |
| 2014-12-31 | 33.94 | $4.56 | 7.44 |
| 2014-09-30 | 33.23 | $3.41 | 9.75 |
| 2014-06-30 | 33.48 | $3.54 | 9.46 |
| 2014-03-31 | 34.07 | $3.66 | 9.31 |
| 2013-12-31 | 32.20 | $3.65 | 8.82 |
| 2013-09-30 | 30.42 | $3.95 | 7.70 |
| 2013-06-30 | 32.07 | $4.02 | 7.98 |
| 2013-03-31 | 33.63 | $4.14 | 8.12 |
| 2012-12-31 | 30.87 | $4.18 | 7.38 |
| 2012-09-30 | 27.91 | $4.11 | 6.79 |
| 2012-06-30 | 24.61 | $4.06 | 6.06 |
| 2012-03-31 | 27.68 | $3.94 | 7.03 |
| 2011-12-31 | 22.91 | $3.88 | 5.90 |
| 2011-09-30 | 25.99 | $3.78 | 6.88 |
| 2011-06-30 | 27.64 | $3.78 | 7.31 |
| 2011-03-31 | 24.90 | $3.61 | 6.90 |
| 2010-12-31 | 23.44 | $3.49 | 6.72 |
| 2010-09-30 | 22.09 | $3.71 | 5.95 |
| 2010-06-30 | 18.82 | $3.57 | 5.27 |
| 2010-03-31 | 26.95 | $3.63 | 7.42 |
| 2009-12-31 | 27.17 | $3.60 | 7.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.278B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| Neogen (NEOG) | United States | $1.268B | 16.22 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |